MATTAWAN, MI February 9, 2006:

MPI Research is commemorating its 10th year of bringing safer, healthier pharmaceutical and biotech products to the world, and would be honored to have you share in our celebration! You will find that as our growth continues, we have expanded our service range in some new and exciting ways. Visit with us to learn about

• non-GLP HST hERG in vitro assessment using the planar perforated patch technology and the Langendorff heart model.
• full immunoassay development and validation services to support preclinical and clinical studies.
• molecular imaging (CT, PET, and SPECT), utilizing specific radiotracers to noninvasively monitor and measure multiple biomolecular processes.

Dr. James Laveglia, Executive Vice President and Director of Research at MPI, reports, “2005 was a landmark year for MPI Research – a year that marked the end of a very successful decade of preclinical pharmaceutical and biotech research. Both our service range and our facilities have grown at a rapid pace. We look forward to greeting our Sponsors and friends to thank them for being a part of our success!”

Take a few moments to relax at our cappuccino café, where you can discuss your preclinical research needs with an experienced MPI study director.

The corporate headquarters of MPI Research is in Mattawan, part of the life sciences corridor of southwest Michigan. This is also the location of its primary site, which is undergoing a major expansion on its 130 acres due to unprecedented business growth. Having been enlarged from 300,000 to 500,000 square feet over the past 18 months, this facility will be expanded to nearly 800,000 square feet in 2006. MPI’s 1,000+ employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, analytical chemistry, computer science, regulatory science, molecular imaging and statistics. They take pride in conducting top quality research for pharmaceutical, animal health and chemical companies as well as governmental agencies.

Home | News